Comparison of GC-MS and EIA Results for the Analysis of Methadone in Oral Fluid

    Volume 50, Issue 4 (July 2005)

    ISSN: 0022-1198

    CODEN: JFSOAD

    Published Online: 25 May 2005

    Page Count: 5


    Hand, C
    Cozart Bioscience Ltd, Abingdon, Oxfordshire

    Reid, C
    Cozart Bioscience Ltd, Abingdon, Oxfordshire

    Baldwin, D
    Cozart Bioscience Ltd, Abingdon, Oxfordshire

    Cooper, G
    Cozart Bioscience Ltd, Abingdon, Oxfordshire

    Wilson, L
    Cozart Bioscience Ltd, Abingdon, Oxfordshire

    Spiehler, V
    Spiehler and Associates, Newport Beach, CA

    (Received 23 December 2004; accepted 12 March 2005)

    Abstract

    The purpose of these studies was to evaluate the performance characteristics of the Cozart® Microplate Enzyme Immunoassay (EIA) for the determination of methadone in oral fluid from patients in a drug misuse treatment program. Oral fluid specimens were collected using the Cozart® RapiScan Collection system from 198 donors who were receiving treatment for their addiction and were monitored for drug misuse. Oral fluid specimens were also collected from forty volunteer donors who were not drug users. The specimens were analyzed in the laboratory by EIA and then analysed for methadone and its main metabolite EDDP by gas chromatography-mass spectrometry (GC-MS). A total of 103 samples were confirmed positive for methadone. The Cozart® Microplate EIA for d-Methadone in oral fluid using a cutoff of 30 ng/mL in diluted oral fluid had a sensitivity of 91.3%±2.8% and a specificity of 100%±1.0% vs. GC-MS.


    Paper ID: JFS2004539

    DOI: 10.1520/JFS2004539

    ASTM International
    is a member of CrossRef.

    Author
    Title Comparison of GC-MS and EIA Results for the Analysis of Methadone in Oral Fluid
    Symposium , 0000-00-00
    Committee E30